CEB-01 by Cebiotex for Soft Tissue Sarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Soft Tissue Sarcoma.

Undernourished household contacts three times more likely to develop TB

Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), is distinct from most germs in its capacity to silently infect individuals for months and even years

April 23, 2024

Study reveals molecular changes in 19 organs due to exercise

The health benefits of exercise are well known but new research shows that the body’s response to exercise is more complex and far-reaching than previously

May 2, 2024

Screen time and autism, TikTok and birth control, fighting disinformation

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Election Day is finally here. What to

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.